>Return-Path: <PharmCare@ade5.pa.man.ac.uk>
>Date: Thu, 30 Jan 1997 09:32:22 +1300
>Subject: Re: Use of Q.O.L. measures in community pharmacies
>From: "PharmCare" <PharmCare@ade5.pa.man.ac.uk>
>To: PharmCare@ade5.pa.man.ac.uk
>
>>Return-Path: <PharmCare@ade5.pa.man.ac.uk>
>>Date: Mon, 13 Jan 1997 09:46:23 +1300
>>Subject: Re: Use of Q.O.L. measures in community pharmacies
>>From: "PharmCare" <PharmCare@ade5.pa.man.ac.uk>
>>To: PharmCare@ade5.pa.man.ac.uk
>>
>>>Return-Path: <PharmCare@ade5.pa.man.ac.uk>
>>>X-Sender: tjgr@pop.interchange.ubc.ca
>>>Date: Thu, 02 Jan 1997 15:24:20 -0800
>>>To: PharmCare <PharmCare@ade5.pa.man.ac.uk>
>>>From: "Timothy-John Grainger-Rousseau, Ph.D." <tjgr@unixg.ubc.ca>
>>>Subject: Re: Use of Q.O.L. measures in community pharmacies
>>>
>>>Brian:
>>>
>>>I've measures QoL when I did my PhD study implementing a PC practice in a
>>>community pharmacy back in 1989-1991. At that time there weren't many
>>>validated short measures or disease specific measures around. I used the
>>>Quality of Well Being Scale ut it was a lot of work besides the other
>>>clinical measure I was assessing and collecting. You can review this on any
>>>on-line reference that abtracts theses.
>>>
>>>Grainger-Rousseau, TJ. Contributions of the community pharmacist to patient
>>>care. PhD Thesis, The Queen's Univeristy of Belfast, Northern Ireland,
>>>1992.pp. 1-330
>>>
>>>The shorter measures like to SF-36 and SF-12 are now available on line see
>>>
>>>http://www.hcia.com/interactive/online.html
>>>
>>>also the Medical Outcomes Trust that has info on recommended measures see
>>>
>>>http://www.outcomes-trust.org/
>>>
>>>The Health Outcomes Institute, Bloomington, MN is also developing a 12 item
>>>questionnaire, they're at version 2.0 now. Contact David Radosevich @ (612)
>>>858-9188.
>>>
>>>From my experience, measuring general QoL in a sample attending community
>>>pharmacy may not demonstrate changes in measrue used since they are probably
>>>at the ceiling of the scale measurement. You'll of course needto supplement
>>>your measures with some disease specific QoL measures depending on what
>>>disease states your sample has.
>>>
>>>TJ
>>>
>>>Timothy-John Grainger-Rousseau, Ph.D.
>>>Assistant Professor
>>>Division of Pharmacy Practice
>>>Faculty of Pharmaceutical Sciences
>>>University of British Columbia
>>>2146 East Mall, Vancouver, B.C.
>>>Canada, V6T 1Z3
>>>
>>>Tel: (604) 822-7181
>>>Fax: (604) 822-7181 or (604) 822-3035
>>>
>>>E-mail: tjgr@unixg.ubc.ca
>>>
>>>
>>>
>>
>>
>>
>
>
>
**************************************************************************
Bruce Chilton BPharm MBA MPS
Lecturer, Pharmacy Practice, Management & Law
School of Pharmacy
University of Otago
PO Box 913
Dunedin
NEW ZEALAND
Telephone & Fax +64 3 479 7149
Email bruce.chilton@stonebow.otago.ac.nz
*************************************
Moderator with Peter Barron
Pharmaceutical Care Discussion Group
PharmWeb
PharmCare@ade5.pa.man.ac.uk
**************************************************************************
|